Moleculin Biotech Inc (MBRX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Walter V. Klemp
Employees:
20
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
713-300-5160
Are you looking for this stock instead?
Date | Ratio |
---|---|
2021-02-01 | 1:6 |
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the. treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in clinical trials for brain tumors and pediatric brain tumors.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|